ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

February 17, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

July 31, 2026

Conditions
Delayed Graft Function
Interventions
BIOLOGICAL

ARGX-117

Intravenous administration of ARGX-117

OTHER

Placebo

Intravenous administration of placebo

Trial Locations (45)

1090

Allgemeines Krankenhaus der Stadt Wien (AKH Wien), Vienna

3000

Universitair Ziekenhuis Leuven, Leuven

3168

Monash Health - Monash Medical Centre, Clayton

6020

Tirol Kliniken - A.o. Landeskrankenhaus Innsbruck, Innsbruck

10032

Columbia University, New York

10126

Azienda Ospedaliero Universitaria Citta della Salute e della Scienza di Torino - Presidio Molinette, Torino

10267

University of Texas Southwestern Medical Center, Dallas

14215

Erie County Medical Center, Buffalo

18014

Hospital Universitario Virgen de las Nieves - Hospital General, Granada

31400

CHU de Toulouse - Hopital Rangueil, Toulouse

33076

CHU Bordeaux - Groupe Hospitalier Pellegrin, Bordeaux

33606

Tampa General Hospital, Tampa

35128

Azienda Ospedale Universita Padova, Padua

37000

CHRU de Tours - Hopital Bretonneau, Tours

38700

CHU Grenoble Alpes - Hopital Michallon, La Tronche

40138

Azienda Ospedaliero Universitaria di Bologna Policlinico di Sant'Orsola, Bologna

41345

Sahlgrenska Universitetssjukhuset, Gothenburg

43210

The Ohio State University, Columbus

46017

Hospital Universitari Doctor Peset, Valencia

50009

Hospital Universitario Miguel Servet, Zaragoza

60612

University of Illinois (UI) Health - Outpatient Care Center, Chicago

75015

Assistance Publique Hopitaux de Paris (AP-HP) - Hopital Necker-Enfants Malades, Paris

75185

Akademiska sjukhuset, Uppsala

90048

Cedars-Sinai Medical Center, Los Angeles

94000

Assistance Publique Hopitaux de Paris (AP-HP) - Hopital Henri Mondor, Créteil

07039

Cooperman Barnabas Medical Center, Livingston

SA 5000

Royal Adelaide Hospital, Adelaide

QLD 4102

Princess Alexandra Hospital, Woolloongabba

3004-561

Centro Hospitalar e Universitario de Coimbra, Coimbra

60156-290

Hospital Geral de Fortaleza, Fortaleza

90020-090

Santa Casa de Misericordia de Porto Alegre - Hospital Dom Vicente Scherer, Porto Alegre

15090-000

Hospital de Base, São Jose Do Rio Preto

05403-000

Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo (HC-FMUSP), São Paulo

H1T 2M4

Hôpital Maisonneuve-Rosemont - Centre de recherche, Montreal

H4A 3J1

McGill University Health Centre - Royal Victoria Hospital, Montreal

V5Z 1M9

Vancouver Coastal Health - Vancouver General Hospital Diamond Healthcare Centre, Vancouver

V6Z 1Y6

Providence Health Care - St. Pauls Hospital, Vancouver

2790-134

Centro Hospitalar de Lisboa Ocidental EPE - Hospital de Santa Cruz, Carnaxide

1069-099

Centro Hospitalar Universitario Lisboa Central EPE - Hospital Curry Cabral, Lisbon

4099-001

Centro Hospitalar Universitario de Santo Antonio, Porto

08916

Hospital Universitari Germans Trias i Pujol (HUGTP), Badalona

08003

Hospital del Mar, Barcelona

08025

Fundacio Puigvert, Barcelona

08035

Hospital Universitario Vall d'Hebron, Barcelona

08907

Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat

Sponsors

Lead Sponsor

All Listed Sponsors
lead

argenx

INDUSTRY

NCT05907096 - ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function | Biotech Hunter | Biotech Hunter